Clinical, Medical and Diagnostics
New dyes and antibody markers for enhanced immunology research
May 02 2024
Bio-Rad Laboratories, Inc has announced the release of three new StarBright™ Red Dyes - StarBright Red 715, 775, and 815 - and the expansion of its StarBright Violet Dye series with 29 additional highly validated antibodies. With a total of 32 dyes now available, Bio-Rad's StarBright Dyes offer enhanced options for conventional and full-spectrum flow cytometry in immunology research.
The StarBright Dyes, proprietary fluorescent nanoparticles conjugated to flow-validated antibodies, provide exceptional brightness with narrow excitation and emission profiles. The new StarBright Red Dyes are excitable by the 640 nm laser, offering brightness comparable to existing dyes while exhibiting minimal background and stability in fixatives.
Compatible with most experimental protocols and flow cytometers, including the Bio-Rad ZE5 Cell Analyser, StarBright Dyes ensure reproducible and consistent staining with minimal lot-to-lot variation. Additionally, these dyes resist photobleaching, maintaining signal integrity even after fixation.
The expanded range of antibody markers includes targets for human, mouse, dog, cow, and pig species, enhancing the versatility of StarBright Violet Dyes for a variety of research applications.
Hilary Mavor, Marketing Director, Life Science Group, Bio-Rad, stated: “The Bio-Rad StarBright Dye portfolio offers superior alternatives to existing dyes, providing researchers with greater choice and flexibility when building multicolour panels in conventional and full-spectrum flow cytometry.”
More information online
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark